Laxmi Dental Limited has announced its participation in a Non-Deal Roadshow (NDR) with Elara Capital, scheduled for April 22, 2026. The company informed both BSE and NSE about the investor meeting through a regulatory filing dated April 17, 2026.

Meeting Details

The roadshow will take place in Chennai through physical meetings, providing investors with opportunities for direct interaction with company officials. The event details are structured as follows:

Regulatory Compliance

The announcement was made pursuant to Regulation 30 read with Para A Part A Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Company Secretary and Compliance Officer Suman Saha signed the regulatory filing, ensuring proper compliance with disclosure requirements.

Discussion Framework

Laxmi Dental Limited has clearly stated that all discussions during the roadshow will be based on publicly available information. The company has emphasized that no unpublished price sensitive information (UPSI) is intended to be discussed during the investor interactions, maintaining transparency and regulatory compliance.

Additional Information

The company has noted that changes to the schedule may occur due to exigencies on the part of participants or the company. Complete details of the roadshow will be made available on the company's website at www.laxmidentallimited.com for stakeholder reference and transparency.

Laxmi dental Limited has secured in-principle approvals from both major stock exchanges for listing equity shares under its Employee Stock Option Scheme 2024. The company announced these significant developments through regulatory filings, marking important milestones in its employee benefits program.

Dual Exchange Approvals

The company has now received approvals from both the National Stock Exchange of India Limited (NSE) and BSE Limited for listing up to 5.00 lakh equity shares. The NSE granted approval through letter Ref. No. NSE/LIST/52967 dated April 08, 2026, while BSE issued its approval via letter DCS/ESOP/IP/TS/017/2026-27 dated April 10, 2026.

Listing Conditions and Requirements

Both exchanges have specified mandatory conditions that must be fulfilled before actual listing and trading of shares. The key requirements include:

• Notification to exchanges under Regulation 10(c) after allotment of securities and credit to beneficiaries' accounts
• Receipt of statutory and other approvals from authorities including SEBI, RBI, and MCA
• Compliance with all exchange guidelines, regulations, and directions
• Adherence to SEBI (LODR) Regulations, 2015 conditions
• Compliance with Companies Act provisions and other applicable laws
• Payment of prescribed fees as determined from time to time

Regulatory Compliance Framework

Laxmi Dental Limited has informed both stock exchanges about these developments in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The approvals are granted under the Securities Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Documentation and Next Steps

Both exchanges have specified comprehensive documentation requirements for final listing approval, including certified copies of statements under SEBI regulations, board resolutions for share allotment, and detailed lists of allottees. The exchanges reserve the right to withdraw approvals if submitted information is found incomplete, incorrect, or misleading.

The company has made the approval letters available on its website at www.laxmidentallimited.com and completed all necessary regulatory disclosures to both exchanges. Trading permissions will be issued by the exchanges upon receipt of notifications under Regulation 10(c) and subject to compliance with stated conditions.